Resources for your practice

IF YOU HAVE QUESTIONS ABOUT NUEDEXTA OR NEED REIMBURSEMENT SUPPORT

CALL 1-855-4NUEDEX (468-3339)
or visit
www.AdvancedPatientServices.com

Document your diagnosis of pseudobulbar affect using ICD-10 code F48.2a,1
 

aThis is intended for reference only. ICD-10-CM codes submitted to the payer must be determined by the provider/physician and accurately describe PBA as the diagnosis for which the patient receives NUEDEXTA treatment.

 

Getting Started

Request a sample to start patients on NUEDEXTA. Eligible healthcare providers can request a free 10-day sample of NUEDEXTA for appropriate patients

Request a sample

Co-Pay Savings

With the NUEDEXTA Co-Pay Card,b most commercially insured patients pay no more than $302

Print a
Co-Pay Card

 

bAvailable to qualifying privately insured patients. Restrictions apply.2

PBA Screening Questionnaire

Center for Neurologic Study-Lability Scale (CNS-LS) for measuring pseudobulbar affect (PBA) symptoms


Download the
Questionnaire

NUEDEXTA Patient Brochure

Share this informational brochure with your patients to learn about NUEDEXTA—the first-and-only FDA-approved treatment for PBA.

Download the full
NUEDEXTA Patient
Brochure

bRestrictions apply. Those eligible for any state or federally funded prescription programs, including Medicare, Medicaid, Medigap, VA, DOD, or TriCare, are not eligible for this program.